Literature DB >> 22225672

Drug policy and the public good: evidence for effective interventions.

John Strang1, Thomas Babor, Jonathan Caulkins, Benedikt Fischer, David Foxcroft, Keith Humphreys.   

Abstract

Debates about which policy initiatives can prevent or reduce the damage that illicit drugs cause to the public good are rarely informed by scientific evidence. Fortunately, evidence-based interventions are increasingly being identified that are capable of making drugs less available, reducing violence in drug markets, lessening misuse of legal pharmaceuticals, preventing drug use initiation in young people, and reducing drug use and its consequences in established drug users. We review relevant evidence and outline the likely effects of fuller implementation of existing interventions. The reasoning behind the final decisions for action might be of a non-scientific nature, focused more on what the public and policy-makers deem of value. Nevertheless, important opportunities exist for science to inform these deliberations and guide the selection of policies that maximise the public good.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22225672     DOI: 10.1016/S0140-6736(11)61674-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

1.  Use of Opioid Agonist Therapy for Medicare Patients in 2013.

Authors:  Anna Lembke; Jonathan H Chen
Journal:  JAMA Psychiatry       Date:  2016-09-01       Impact factor: 21.596

2.  The role of first use of inhalants within sequencing pattern of first use of drugs among Brazilian university students.

Authors:  João Maurício Castaldelli-Maia; Sérgio Nicastri; Lúcio Garcia de Oliveira; Arthur Guerra de Andrade; Silvia S Martins
Journal:  Exp Clin Psychopharmacol       Date:  2014-08-25       Impact factor: 3.157

3.  Use transition between illegal drugs among Brazilian university students.

Authors:  João Mauricio Castaldelli-Maia; Silvia S Martins; Lúcio Garcia de Oliveira; Margriet van Laar; Arthur Guerra de Andrade; Sergio Nicastri
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-06       Impact factor: 4.328

4.  Barriers and Enablers to Integrating Mental Health into Primary Care: A Policy Analysis.

Authors:  Anna Durbin; Janet Durbin; Jennifer M Hensel; Raisa Deber
Journal:  J Behav Health Serv Res       Date:  2016-01       Impact factor: 1.505

5.  "In their perception we are addicts": social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam.

Authors:  Cecilia Tomori; Vivian F Go; Le Nhan Tuan; Nguyen Mai Huong; Nguyen Thanh Binh; Carla E Zelaya; David D Celentano; Do Tuan Dat; Vu Minh Quan
Journal:  Int J Drug Policy       Date:  2014-04-28

Review 6.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

7.  Drug use on both sides of the US-Mexico border.

Authors:  Guilherme Borges; Sarah E Zemore; Ricardo Orozco; Cheryl J Cherpitel; Priscilla Martínez; Lynn Wallisch
Journal:  Salud Publica Mex       Date:  2018 Jul-Aug

8.  Impact of length of injecting career on HIV incidence among people who inject drugs.

Authors:  Jacqueline Montain; Lianping Ti; Kanna Hayashi; Paul Nguyen; Evan Wood; Thomas Kerr
Journal:  Addict Behav       Date:  2016-02-16       Impact factor: 3.913

9.  DSM-5 latent classes of alcohol users in a population-based sample: results from the São Paulo Megacity Mental Health Survey, Brazil.

Authors:  João Mauricio Castaldelli-Maia; Camila M Silveira; Erica R Siu; Yuan-Pang Wang; Igor A Milhorança; Clóvis Alexandrino-Silva; Guilherme Borges; Maria C Viana; Arthur G Andrade; Laura H Andrade; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

Review 10.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.